tiprankstipranks
Trending News
More News >

Mark Neumann Insider Profile

4 Followers
Mark Neumann, EVP & CCO at Intra-Cellular Therapies, holds 0.00 shares in Intra-Cellular Therapies (Ticker: ITCI), holds ― shares in Veradermics, Incorporated (Ticker: MANE).
tipranks
Mark Neumann

Mark Neumann
Intra-Cellular Therapies (ITCI)
EVP & CCO

Ranked #85,870 out of 106,013 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-46.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Mark Neumann does not currently own shares as a corporate insider.
A breakdown of Mark Neumann's holdings

Insider Roles

Veradermics, Incorporated
(MANE)
Chief Commercial Officer, Strategy Officer
Roles that Mark Neumann holds in companies

Most Profitable Insider Trade

Stock:
Intra-Cellular Therapies
(ITCI)
Rating:Informative Sell
Date:Aug 09, 2023 - Aug 09, 2024
Return:-26.70%
The most profitable trade made by Mark Neumann

Mark Neumann's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ITCI
Intra-Cellular Therapies
Apr 02, 2025
Uninformative Sell
6.97M
$0.00
Veradermics, Incorporated
Chief Commercial Officer, Strategy Officer
List of latest transactions for each holding click on a transaction to see Mark Neumann's performance on stock

Mark Neumann insider profile FAQ

What is the percentage of profitable transactions made by Mark Neumann?
The percentage of profitable transactions made by Mark Neumann is 0%.
    What is the average return per transaction made by Mark Neumann?
    The average return per transaction made by Mark Neumann is -46.10%.
      What stocks does Mark Neumann hold?
      Mark Neumann holds: ITCI, MANE stocks.
        What was Mark Neumann’s latest transaction?
        Mark Neumann latest transaction was an Uninformative Sell of $6.97M.
          What was Mark Neumann's most profitable transaction?
          Mark Neumann’s most profitable transaction was an Informative Sell of ITCI stock on August 9, 2023. The return on the trade was -26.70%.
            What is Mark Neumann's role in Intra-Cellular Therapies?
            Mark Neumann's role in Intra-Cellular Therapies is EVP & CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.